World Journal of Surgery

, Volume 35, Issue 5, pp 1072–1084

Improvement of Long-Term Outcomes in Hepatitis C Virus Antibody–Positive Patients with Hepatocellular Carcinoma after Hepatectomy in the Modern Era

  • Ken Shirabe
  • Kazuki Takeishi
  • Akinobu Taketomi
  • Hideaki Uchiyama
  • Hiroto Kayashima
  • Yoshihiko Maehara
Article
  • 108 Downloads

Abstract

Background

The present study was conducted to clarify the causes of recent improvement of outcomes after hepatectomy in patients with hepatitis C (HC)–related hepatocellular carcinoma (HCC).

Methods

From 1990 to 2006, 323 curative liver resections for HC-HCC were performed in our department. The patients were divided into two groups: early period (1990–1999: n = 221) and the late period (2000–2006: n = 102). Prognostic factors were determined to clarify the cause of the survival improvement in the modern era.

Results

The overall survival rates for the patients in the early and late periods were 54.9 and 70.3% at 5 years, respectively (P = 0.0005). There was no difference in the recurrence-free survival rates between the two groups, although both survival without recurrence (P = 0.0003) and survival after recurrence (P = 0.0063) were significantly better in the late period than in the early period. Patients with better liver function, patients with interferon (IFN) therapy and patients with subsegmentectomy were selected more frequently, and the incidence of blood transfusion was decreased in the late period below the level recorded in the early period. For recurrent HCC, lipiodolization decreased and local ablation therapy increased in the late period. The independent prognostic factors for overall survival were preoperative serum levels of albumin and alanine aminotransferase, histological liver cirrhosis, tumor size, intrahepatic metastasis, histological grade, blood transfusion, and IFN therapy.

Conclusions

In HC-HCC, survival was improved in the late period of the present study. Selection of patients with good liver function, no blood transfusion with reduction of blood loss, anti-hepatitis C virus therapy with IFN, and introduction of local ablation therapy for HCC recurrence may be related to the improved survival.

Abbreviations

HCC

Hepatocellular carcinoma

HC

Hepatitis C

AST

Aspartate aminotransferase

ALT

Alanine aminotransferase

ICGR15

Indocyanine green retention test at 15 min

NLC

No liver cirrhosis

LC

Liver cirrhosis

AFP

Alpha-fetoprotein

DCP

Des-gamma-carboxy prothrombin

IFN

Interferon

SVR

Sustained viral responder

NR

Non-responder

LPD

Lipiodolization

RCTs

Randomized controlled trials

References

  1. 1.
    Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15:948–963PubMedCrossRefGoogle Scholar
  2. 2.
    Tsai JF, Jeng JE, Ho MS et al (1997) Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer 76:968–974PubMedCrossRefGoogle Scholar
  3. 3.
    Scherlock S (1994) Viruses and hepatocellular carcinoma. Gut 35:828–832CrossRefGoogle Scholar
  4. 4.
    Adachi E, Maeda T, Matsumata T et al (1995) Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108:768–775PubMedCrossRefGoogle Scholar
  5. 5.
    Shirabe K, Takenaka K, Taketomi A et al (1996) Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 77:1050–1055PubMedCrossRefGoogle Scholar
  6. 6.
    Shirabe K, Wakiyama S, Gion T et al (2007) Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma—results of 152 resected cases. Hepatogastroenterology 54:2084–2087PubMedGoogle Scholar
  7. 7.
    Shirabe K, Shimada M, Kajiyama K et al (1998) Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 83:2312–2316PubMedCrossRefGoogle Scholar
  8. 8.
    Sasaki Y, Yamada T, Tanaka H et al (2006) Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg 244:771–780PubMedCrossRefGoogle Scholar
  9. 9.
    Takenaka K, Kawahara N, Yamamoto K et al (1996) Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131:71–76PubMedGoogle Scholar
  10. 10.
    Taura K, Ikai I, Hatano E et al (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 244:265–273PubMedCrossRefGoogle Scholar
  11. 11.
    Sasaki A, Iwashita Y, Shibata K et al (2006) Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg 30:1567–1578PubMedCrossRefGoogle Scholar
  12. 12.
    Poon RT, Fan ST, Lo CM et al (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70PubMedCrossRefGoogle Scholar
  13. 13.
    Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer, 2 English edn. Kanehara, TokyoGoogle Scholar
  14. 14.
    Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293PubMedCrossRefGoogle Scholar
  15. 15.
    Shirabe K, Itoh S, Yoshizumi T et al (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95:235–240PubMedCrossRefGoogle Scholar
  16. 16.
    Kanematsu T, Furuta T, Takenaka K et al (1989) A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10:98–102PubMedCrossRefGoogle Scholar
  17. 17.
    Sugimachi K, Maehara S, Tanaka S et al (2001) Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 8:410–416PubMedCrossRefGoogle Scholar
  18. 18.
    Tanaka S, Shimada M, Shirabe K et al (2005) A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Hepatogastroenterology 52:862–865PubMedGoogle Scholar
  19. 19.
    Takano S, Yokosuka O, Imazeki F et al (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21:650–655PubMedCrossRefGoogle Scholar
  20. 20.
    Shimada M, Gion T, Hamatsu T et al (1999) Evaluation of major hepatic resection for small hepatocellular carcinoma. Hepatogastroenterology 46:401–406PubMedGoogle Scholar
  21. 21.
    Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475PubMedCrossRefGoogle Scholar
  22. 22.
    Dahiya D, Wu JT, Lee CF et al (2010) Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 147:676–685PubMedCrossRefGoogle Scholar
  23. 23.
    Shirabe K, Kajiyama K, Abe T et al (2009) Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio. J Gastroenterol Hepatol 24:1431–1436PubMedCrossRefGoogle Scholar
  24. 24.
    Yamashita Y, Taketomi A, Itoh S et al (2007) Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 205:19–26PubMedCrossRefGoogle Scholar
  25. 25.
    Kanematsu T, Takenaka K, Matsumata T et al (1984) Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 199:51–56PubMedCrossRefGoogle Scholar
  26. 26.
    Ikeda K, Arase Y, Saitoh S et al (2000) Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—a prospective randomized study of hepatitis C virus related liver cancer. Hepatology 32:228–232PubMedCrossRefGoogle Scholar
  27. 27.
    Kubo S, Nashiguchi S, Hirohashi K et al (2002) Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 89:418–422PubMedCrossRefGoogle Scholar
  28. 28.
    Shiratori Y, Shiina S, Teratani T et al (2003) Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 138:299–306PubMedGoogle Scholar
  29. 29.
    Mazzaferro V, Romito R, Schiavo M et al (2006) Prevention of hepatocellular carcinoma recurrence with alpha-interferon after hepatic resection in HCV cirrhosis. Hepatology 44:1543–1554PubMedCrossRefGoogle Scholar
  30. 30.
    Kudo M, Sakaguchi Y, Chung H et al (2007) Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Oncology 72:s132–s138CrossRefGoogle Scholar
  31. 31.
    Uenishi T, Kubo S, Hirohashi K et al (2002) Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 24:404–412PubMedCrossRefGoogle Scholar
  32. 32.
    Matsumata T, Ikeda Y, Hayashi H et al (1995) The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer 72:1866–1871CrossRefGoogle Scholar
  33. 33.
    Shiba H, Ishida Y, Wakiyama S et al (2009) Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 13:1636–1642PubMedCrossRefGoogle Scholar
  34. 34.
    Tralhão JG, Kayal S, Dagher I et al (2007) Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology 54:1200–1206PubMedGoogle Scholar
  35. 35.
    Cherqui D, Laurent A, Mocellin N et al (2009) Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 250:738–746PubMedCrossRefGoogle Scholar
  36. 36.
    Belghiti J (2009) Resection and liver transplantation for HCC. J Gastroenterol 44(suppl 19):132–135PubMedCrossRefGoogle Scholar
  37. 37.
    Cucchetti A, Vitale A, Gaudio MD et al (2010) Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 10:619–627PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2011

Authors and Affiliations

  • Ken Shirabe
    • 1
  • Kazuki Takeishi
    • 1
  • Akinobu Taketomi
    • 1
  • Hideaki Uchiyama
    • 1
  • Hiroto Kayashima
    • 1
  • Yoshihiko Maehara
    • 1
  1. 1.Department of Surgery and Science, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan

Personalised recommendations